Vial

FEBRUARY 29, 2024

Contract research organizations (CROs) are an integral partner of the drug development process, as they play a pivotal role supporting clinical trial conduct for pharmaceutical, biotechnology, and medical device sponsor companies. A rise of clinical trial outsourcing due to cost management, globalization, and digitalization.

Clinical Trials 52

Clinical Trials Trials Clinical Research Marketing 52

Drug Discovery World

AUGUST 3, 2023

Michael Sassano, CEO at SOMAÍ Pharmaceuticals, shared with DDW that it is estimated that there will be 340,000 medicinal cannabis users in Europe in 2022 alone, and the overall market is estimated to grow over 500% over the next three years – with the market value in Germany alone poised to hit over €7 billion by 2027 5.

Clinical Trials 130

Clinical Trials Regulations Production FDA 130

Drug Discovery World

NOVEMBER 17, 2022

billion by 2027. . According to SkyQuest Technology, the pharmaceutical industry is worth an estimated $2 trillion dollars and is expected to grow at 5% a year to 2025. However, the development of drugs takes decades which is too long for most biotech start- ups looking for fast-track drug development programs.

Engineering 130

Engineering Molecular Biology Synthetic Chemistry DNA 130

Agency IQ

MAY 17, 2024

How have pre-submission meetings for generic drug applicants changed under GDUFA III? Under GDUFA III, the scope and purpose of pre-submission meetings for generic drug developers has changed. The generic drug user fee program is currently on its third iteration (i.e.,

Science 40

Science FDA Production Drugs 40

Drug Discovery World

JANUARY 11, 2023

Pegcetacoplan (EMPAVELI/ASPAVELI/APL-2) developed by Apellis Pharmaceuticals Inc. As one of the few drugs to have completed Phase III trials for GA, pegcetacoplan is expected to be the first drug to launch for geographic atrophy (GA) or ‘dry late age-related macular degeneration (AMD)’, which has no approved pharmacotherapy. .

Drugs 130

Drugs Trials Pharmaceuticals Treatment 130

Drug Discovery World

NOVEMBER 15, 2022

If a pharmaceutical company is racing to identify a new vaccine, for instance, then waiting for three weeks to receive DNA sequences each time can slow down the development process compared to competitors who might have faster timelines.” . Synthetic libraries for antibody drug discovery .

DNA 246

DNA Engineering Drugs Vaccine 246

Agency IQ

FEBRUARY 15, 2024

If you’re looking for something specific, we recommend using the search function in your browser (Ctrl-F) to look for keywords of interest.

FDA 40

FDA Science Biosimilars Production 40